Uncovering Potential Securities Fraud: Levi and Korsinsky Investigate Atara Biotherapeutics Inc. (ATRA)

Uncovering Potential Securities Fraud: Levi and Korsinsky Investigate Atara Biotherapeutics Inc. (ATRA) Description NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Atara Biotherapeutics, Inc. (“Atara Biotherapeutics, Inc.”) (NASDAQ:ATRA) concerning possible violations of federal securities laws.

Read More »

Mark Your Calendars: Parker’s Fiscal 2025 Second Quarter Earnings Announcement and Conference Call Set for January 30th!

Mark Your Calendars: Parker’s Fiscal 2025 Second Quarter Earnings Announcement and Conference Call Set for January 30th! Description: CLEVELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it will release its fiscal 2025 second quarter earnings

Read More »

Breaking News: Phio Pharmaceuticals Successfully Completes $1.83 Million Direct Offering Under Nasdaq Rules!

Breaking News: Phio Pharmaceuticals Successfully Completes $1.83 Million Direct Offering Under Nasdaq Rules! Raised approximately $12.08 million in gross proceeds since beginning of December 2024 Proceeds intended to be directed for development costs to be incurred in connection with PH-762 clinical activities Marlborough, Massachusetts–(Newsfile Corp. – January 21, 2025) –

Read More »